Suppr超能文献

通过液相色谱-串联质谱法(LC-MS/MS)定量测定在-20°C冷冻三年的人血浆中氢吗啡酮的长期稳定性

Long-Term Stability of Hydromorphone in Human Plasma Frozen at -20°C for Three Years Quantified by LC-MS/MS.

作者信息

Wehrfritz Andreas, Schmidt Stefanie, Ihmsen Harald, Schüttler Jürgen, Jeleazcov Christian

机构信息

Department of Anesthesiology, University Hospital Erlangen, Friedrich-Alexander-University of Erlangen-Nürnberg (FAU), Krankenhausstrasse 12, 91054 Erlangen, Germany.

出版信息

Int J Anal Chem. 2022 Jun 28;2022:3645048. doi: 10.1155/2022/3645048. eCollection 2022.

Abstract

The long-term stability of drugs under normal laboratory storage conditions (-20°C) for years is important for research purposes, clinical re-evaluation, and also for forensic toxicology. To evaluate the stability of the analgesic opioid hydromorphone, 44 human frozen plasma samples of a former clinical trial were reanalyzed after at least three years. Blood samples were disposed using solid-phase extraction with an additional substitution of stable isotope labelled hydromorphone as an internal standard. Hydromorphone concentrations were determined by ultra-performance liquid chromatography (UPLC) with gradient elution, followed by tandem mass spectrometry with electrospray ionization. Calibration curves demonstrated linearity of the assay in the concentration range of 0.3-20 ng/mL hydromorphone. The limit of detection of the hydromorphone plasma concentration was 0.001 ng/mL, and the lower limit of quantification was 0.3 ng/mL. Intra- and interassay errors did not exceed 16%. The percentage deviation of the measured hydromorphone plasma concentrations between the reanalysis and the first analysis was -1.07% ± 14.8% (mean ± SD). These results demonstrate that hydromorphone concentration in human plasma was stable when the samples were frozen at -20°C over three years. This finding is of value for re-evaluations or delayed analyses for research purposes and in pharmacokinetic studies, such as in forensic medicine.

摘要

对于研究目的、临床重新评估以及法医毒理学而言,药物在正常实验室储存条件(-20°C)下数年的长期稳定性至关重要。为评估镇痛阿片类药物氢吗啡酮的稳定性,对之前一项临床试验的44份人类冷冻血浆样本在至少三年后进行了重新分析。血样采用固相萃取处理,并额外加入稳定同位素标记的氢吗啡酮作为内标。氢吗啡酮浓度通过超高效液相色谱(UPLC)梯度洗脱,随后进行电喷雾电离串联质谱法测定。校准曲线表明该测定法在0.3 - 20 ng/mL氢吗啡酮浓度范围内呈线性。氢吗啡酮血浆浓度的检测限为0.001 ng/mL,定量下限为0.3 ng/mL。批内和批间误差不超过16%。重新分析与首次分析之间测得的氢吗啡酮血浆浓度的百分比偏差为-1.07% ± 14.8%(均值 ± 标准差)。这些结果表明,当样本在-20°C冷冻三年时,人血浆中的氢吗啡酮浓度是稳定的。这一发现对于研究目的的重新评估或延迟分析以及药代动力学研究(如法医学研究)具有价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7014/9256429/68bb5b92a241/IJAC2022-3645048.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验